Correlation of the oxygen radical activity and antioxidants and severity in critically ill surgical patients – study protocol

  • Hongjin Shim1,

    Affiliated with

    • Ji Young Jang2,

      Affiliated with

      • Seung Hwan Lee2 and

        Affiliated with

        • Jae Gil Lee2Email author

          Affiliated with

          World Journal of Emergency Surgery20138:18

          DOI: 10.1186/1749-7922-8-18

          Received: 23 February 2013

          Accepted: 26 April 2013

          Published: 3 May 2013

          Abstract

          Background

          Surgical patients who require an emergent operation commonly have severe sepsis or septic shock, followed by high morbidity and mortality rates.

          Despite advances in treatment however, no predictable markers are available. In severe sepsis, many pathophysiologic mechanisms are involved in progression to organ failure, and oxygen free radical and antioxidants are known to contribute to this process. Oxygen free radical and antioxidants contribute to progression of organ failure in severe sepsis. In fact, oxygen radical activity has been reported to be correlated with disease severity and prognosis in patients with severe sepsis or septic shock. Accordingly, we aim to assess the usefulness of oxygen free radical and antioxidant concentrations to predict the disease severity and mortality in a cohort of critically ill surgical patients.

          Methods/Design

          This is a prospective observation study including patient demographic characteristics, clinical information, blood sampling/serum oxygen radical activity, serum antioxidant activity, serum antioxidant concentrations (zinc, selenium and glutamate), disease severity scores, outcomes, lengths of stay in intensive care unit, hospital 30-day mortality.

          Keywords

          Oxygen radical activity Antioxidant activity Sepsis Critically ill patient Zinc Selenium Glutamate

          Background

          Critically ill surgical patients usually have a septic status combined with severe systemic inflammation and shock. Sepsis is commonly caused by a gastrointestinal tract perforation, bowel ischemia, or postoperative complications, such as, pneumonia, intra-abdominal infection, or anastomotic leakage. Severe systemic inflammation and sepsis can cause organ failure with high risk of mortality (4 ~ 15% vs. 1%). Sepsis affects about 18 million people annually, with a mortality rate of 25% for uncomplicated cases and 80% in patients developing multi-organ failure syndrome [1].

          Prognostic markers like natriuretic peptide (NP), B-type natriuretic peptide (BNP), or pro-BNP are used to predict postoperative cardiac complications after cardiac or non-cardiac surgery, while procalcitonin is commonly used as prognostic marker and indicator of mortality and antibiotics usage in septic patients. In addition, lactate clearance was recently reported to be a useful indicator of resuscitation and prognosis in severe sepsis [2, 3]. Furthermore, some scoring systems, such as, the acute physiologic and chronic health evaluation (APACHE) II, the sequential organ failure assessment (SOFA), and multiple organ dysfunction score (MODS) systems, are also used to evaluate critically ill patient’s condition. However, no clinically adaptable markers, except lactate clearance and procalcitonin, are available for determining the outcomes of critically ill surgical patients with severe sepsis. Inflammatory processes after infection are known to involve cells, inflammatory mediators, cytokines, pro-inflammatory substances, nitric oxide, arachidonic acid metabolites, and oxygen free radicals. These mediate and induce organ injury leading to organ failure [410]. Recently, many reports have been issued on the roles of oxygen free radicals and antioxidants, such as, glutamine, zinc, and selenium, which act as cofactors of glutathione peroxidase [11, 12]. Oxygen free radicals (OFR) cause oxidative damage in cells, which lead to DNA damage and mitochondrial dysfunction culminates in cell death [1315]. There is evidence that oxidative stress caused by reactive oxygen species(ROS) in sepsis is characterized by tissue ischemia reperfusion injury and intense systemic inflammatory response [1619]. Furthermore, oxidative stress and OFR impair the microcirculation, which induce acute renal failure, and have been correlated with sepsis severity and sepsis-induced morbidity. In sepsis, the protective role of antioxidants against oxidative stress has been known for more than 15 years [2022]. Supplementation with antioxidants, such as, glutamine, zinc, and selenium may decrease oxidative stress and increase antioxidant activity, but apparently, do not affect mortality [2328]. Early recognition of oxidative damage in sepsis by assessment of oxidative stress biomarkers is an actual topic for future research [29, 30].

          Methods

          Aim

          The purpose of the study is to assess the usefulness of the concentration of the oxygen free radical and antioxidants to predict the severity and mortality of the critically ill surgical patients.

          Study population

          This prospective study will be performed over 2-year periods (May 2012 ~ April 2014) in single institution. About 50 patients having severe sepsis or septic shock requiring emergency operation due to the bowel perforation or strangulation will be included.

          Study design

          This study will not change or modify the clinical practices of the participitating physicians. Patients are enrolled after acquisition of the informed consent approved by a Severance hospital institutional review board (Approval No. of IRB: 4-2012-0188).

          Blood sample is drawn at 1st day, 3rd day, and 7th day after admitting to intensive care unit (ICU) regardless of the disposition of the patients after discharge from the ICU.

          The primary endpoint of this study is to evaluate the correlation of the level of oxygen radical activity and severity of the patients. And secondary endpoints are (1) correlation of the level of oxygen radical activity and outcome, i.e., LOS in ICU and hospital, 30 day mortality, in-hospital mortality; (2) correlation of the level of antioxidant and severity and outcome of the patients; (3) relationship of the level of the oxygen radical activity and antioxidants.

          Data collection

          Investigators have collected the data including the followings: (1) patient characteristics, i.e., demographic data, severity of sepsis (severe sepsis or septic shock), presence of shock; (2) severity score for 7 days in ICU, i.e., APACHE II score, SOFA score, MODS; (3) clinical progress, i.e., vital signs, daily intake and output; (4) clinical outcomes, i.e., duration of shock, use of mechanical ventilation (MV), duration of MV, length of stay(LOS) in ICU, LOS in hospital, 30 day mortality, in-hospital mortality, complications. Blood samples are drawn to check the level of oxygen radical activity, antioxidation activity, level of the antioxidant (zinc, selenium, and glutamate) (Table 1).
          Table 1

          Collection of dataset of the enrolled patients

          Day of ICU*admission

          APACHE II**score

          Severity scoring (MODS, SOFA)

          Clinical courses (Vasopressors, Shock, MV§, Complications)

          Oxygen radical activity and antioxidation activity

          Antioxidants (Zn, Se, Glutamate)

          1st day

          O

          O

          O

          O

          O

          2nd day

            

          O

            

          3rd day

           

          O

          O

          O

          O

          4th day

            

          O

            

          5th day

            

          O

            

          6th day

            

          O

            

          7th day

           

          O

          O

          O

          O

          * ICU intensive care unit, ** APACHE II acute physiology and chronic health evaluation II, MODS multi-organ dysfunction score, SOFA sequential organ failure assessment, § MV mechanical ventilation, Zn zinc, Se selenium.

          Oxygen radical activity and antioxidation activity are assessed using CR3000® (Callegari 1930, Italy). Free oxygen radicals test (FORT) kit check the serum H2O2 level directly as oxygen radical. Free oxygen radicals detection (FORD) kit assess the antioxidation activity that check the reactivity with vitamic C, Trolox, albumin, and glutathione to free radical – chromogen.

          The levels of the zinc, selenium and glutamate are assessed in the laboratory.

          Statistical analysis

          The results will be expressed as standard statistical metrics: median (range), mean ± standard deviation for continuous variables.

          The primary endpoint of this study is to evaluate the correlation of the level of oxygen radical activity and severity of the patients.

          And secondary endpoints are (1) correlation of the level of oxygen radical activity and outcome, i.e., LOS in ICU and hospital, 30 day mortality, in-hospital mortality; (2) correlation of the level of antioxidant and severity and outcome of the patients; (3) relationship of the level of the oxygen radical activity and antioxidants.

          Comparison will be performed using the Student’s t-test and chi-test for the relationship of the oxygen radical activity and severity, and Student’s t-test and logistic regression test for the relationship of the oxygen radical activity and antioxidants, and outcomes. Statistical significance will be defined as a p-value less than 0.05 (p<0.05).

          Inclusion criteria

          Patients with severe sepsis or septic shock undergoing emergency surgery due to bowel perforation or strangulation will be screened to enroll the study. And patients requiring ICU care due to postoperative septic complications, such as pneumonia, bacteremia or peritoneal abscess or leakage. After acquesition of the informed consent, they will be assigned as to study.

          Exclusion criteria

          The patients are excluded followings; (1) age < 20 years or > 80 years old; (2) other type shock except sepsis; (3) immune compromised patients, i.e., post-transplant status requiring immunosuppressant, patients using steroid due to immune disorders or other disease, patients having chemotherapeutic agents due to advanced malignancy; (4) patients who not agree the informed consent.

          Declarations

          Authors’ Affiliations

          (1)
          Department of Surgery, Yonsei University Wonju College of Medicine
          (2)
          Department of Surgery, Yonsei University College of Medicine

          References

          1. Galley H: Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010, 14:230.PubMed
          2. Noveanu M, Mebazaa A, Mueller C: Cardiovascular biomarkers in the ICU. Curr Opin Crit Care 2009, 15:377–383.PubMedView Article
          3. Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J: Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007, 22:232–239.PubMedView Article
          4. Kotsovolis G, Kallaras K: The role of endothelium and endogenous vasoactive substances in sepsis. Hippokratia 2010, 14:88–93.PubMed
          5. Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999, 276:R265-R276.PubMed
          6. van der Poll T, van Zoelen MA, Wiersinga WJ: Regulation of pro-and anti-inflammatory host responses. Contrib Microbiol 2011, 17:125–136.PubMedView Article
          7. Gustot T: Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011, 17:153–159.PubMedView Article
          8. Galley HF: Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011, 107:57–64.PubMedView Article
          9. Aksu U, Demirci C, Ince C: The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitri oxide. Contrib Nephrol 2011, 174:119–128.PubMedView Article
          10. Schulte J, Struck J, Kohrle J, Muller B: Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock 2011, 35:460–465.PubMedView Article
          11. Berger M, Chiolero R: Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007, 35:S584-S590.PubMedView Article
          12. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O: Oxidative stress and antioxidant defense. World Allergy Organ J 2012, 5:9–19.PubMedView Article
          13. Dare A, Phillips A, Hickey A, Mittal A, Loveday B, Thompson N: A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Bio Med 2009, 47:1517–1525.View Article
          14. Rocha M, Herance R, Rovira S, Hernandez-Mijares A, Victor VM: Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 2012, 12:161–178.PubMedView Article
          15. Hatwalne MS: Free radical scavengers in anaesthesiology and critical care. Indian J Anaesth 2012, 56:227–233.PubMedView Article
          16. Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ: The role of oxidative stress in adult critical care. Free Radic Biol Med 2006, 40:398–406.PubMedView Article
          17. Abiles J, de la Cruz AP, Castano J, Rodriquez-Elvira M, Aquavo E, Moreno-Torres R: Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care 2006, 10:R146.PubMedView Article
          18. Huet O, Dupic L, Harrois A, Duranteau J: Oxidative stress and endothelial dysfunction during sepsis. Front Biosci 2011, 16:1986–1995.PubMedView Article
          19. Kumar Y, Singh G, Davidson B: Free radical and antioxidant levels in patients with secondary peritonitis and their prognostic significance. Dig Surg 2007, 24:331–337.PubMedView Article
          20. Oldham KM, Bowen PE: Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 1998, 98:1001–1008.PubMedView Article
          21. Cadenas S, Cadenas A: Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology 2002, 180:45–63.PubMedView Article
          22. Nathens A, Neff M, Jurkovich G: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002, 236:814–822.PubMedView Article
          23. Oliveira GP, Dias CM, Pelosi P, Rocco PR: Understanding the mechanisms of glutamine action in critically ill patients. An Acad Bras Cienc 2010, 82:417–430.PubMedView Article
          24. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG: Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542.PubMedView Article
          25. Linko R, Karlsson S, Pettilä V, Varpula T, Okkonen M, Lund V: Serum zinc in critically ill adult patients with acute respiratory failure. Acta Anaesthesiol Scand 2011, 55:615–621.PubMedView Article
          26. Cander B, Dundar ZD, Gul M, Girisgin S: Prognostic value of serum zinc levels in critically ill patients. J Crit Care 2011, 26:42–46.PubMedView Article
          27. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A: High dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 2001, 37:808–815.View Article
          28. Giladi AM, Dossett LA, Fleming SB, Abumrad NN, Cotton BA: High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Injury 2011, 42:78–82.PubMedView Article
          29. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L: Oxidative stress in surgery in an ageing population: pathophysiology and therapy. Exp Gerontol 2013, 48:45–54.PubMedView Article
          30. von Dessauer B, Bongain J, Molina V, Quilodran J, Castillo R, Rodrigo R: Oxidative stress as a novel target in pediatric sepsis management. J Crit Care 2011, 26:103.e1–103.e7.View Article

          Copyright

          © Shim et al.; licensee BioMed Central Ltd. 2013

          This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          Advertisement